EUVIMEDEuropean Health Evidence
Uhr 10/10Sources Journal Tree
Easy Demo

Lokaler Crossref-Datenbestand · journal-article

Longitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progression

Guoyu Lan, Wang Liao, Mingxing Jiang, Jiayi Zhu, Wenqing Ran, Fernando Gonzalez‐Ortiz, Xiang Fan, Hongjie Yang, Dai Shi, Laihong Zhang, Anqi Li, Yue Cai, Pan Sun, Zhengbo He, Xin Zhou, Jie Yang, Yalin Zhu, Mingxu Li, Wenjing Huang, Binhui Liu, Yiying Wang, Xinyue Ma, Rong Ma, Yimei Zhang, Chao Huang, Zhen Liu, Qingyong Wang, Liemin Zhou, Fang Xie, Ying Han, Zhen Liang, Xuhui Chen, Mengjie Dong, Guanxun Cheng, Lu Wang, Benyan Luo, Yan‐jiang Wang, Xiaochun Chen, Jiawei Xin, Guoping Peng

Alzheimer's & Dementia · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract INTRODUCTION Longitudinal diagnostic and prognostic validity of plasma phosphorylated tau217 (p‐tau217) in Alzheimer's disease (AD) remains uncertain. METHODS In this multi‐cohort study of 2117 individuals, we established baseline plasma p‐tau217 thresholds for amyloid‐β–positron emission tomography (Aβ‐PET) and assessed their longitudinal classification stability and prognostic relevance for AD‐related outcomes. RESULTS Baseline‐defined cutoffs achieved high and sustained accuracy (86%–95%) for Aβ‐PET positivity over up to 5 years of follow‐up. Longitudinally, most p‐tau217–positive individuals remained stable (93%–98%), whereas the intermediate zone group progressed more to positive (44%–78%) than p‐tau217–negative individuals (4%–21%). Participants with stable‐positive and progress‐to‐positive p‐tau217 profiles more frequently exhibited Aβ abnormalities (90%–100% and 64%–96%, respectively) and experienced accelerated tau accumulation, hippocampal atrophy, and incident dementia compared to those with a stable‐negative p‐tau217 profile. DISCUSSION These findings support the high stability and Aβ‐PET classification performance of longitudinal plasma p‐tau217 monitoring in AD, providing a scalable tool for risk stratification and disease monitoring.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Guoyu Lan, Wang Liao, Mingxing Jiang, Jiayi Zhu, Wenqing Ran, Fernando Gonzalez‐Ortiz, Xiang Fan, Hongjie Yang, Dai Shi, Laihong Zhang, Anqi Li, Yue Cai, Pan Sun, Zhengbo He, Xin Zhou, Jie Yang, Yalin Zhu, Mingxu Li, Wenjing Huang, Binhui Liu, Yiying Wang, Xinyue Ma, Rong Ma, Yimei Zhang, Chao Huang, Zhen Liu, Qingyong Wang, Liemin Zhou, Fang Xie, Ying Han, Zhen Liang, Xuhui Chen, Mengjie Dong, Guanxun Cheng, Lu Wang, Benyan Luo, Yan‐jiang Wang, Xiaochun Chen, Jiawei Xin, Guoping Peng
Quelle
Alzheimer's & Dementia
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
1552-5260, 1552-5279
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Guoyu Lan, Wang Liao, Mingxing Jiang, Jiayi Zhu, Wenqing Ran, Fernando Gonzalez‐Ortiz, Xiang Fan, Hongjie Yang, Dai Shi, Laihong Zhang, Anqi Li, Yue Cai, Pan Sun, Zhengbo He, Xin Zhou, Jie Yang, Yalin Zhu, Mingxu Li, Wenjing Huang, Binhui Liu, Yiying Wang, Xinyue Ma, Rong Ma, Yimei Zhang, Chao Huang, Zhen Liu, Qingyong Wang, Liemin Zhou, Fang Xie, Ying Han, Zhen Liang, Xuhui Chen, Mengjie Dong, Guanxun Cheng, Lu Wang, Benyan Luo, Yan‐jiang Wang, Xiaochun Chen, Jiawei Xin, Guoping Peng (2026). Longitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progression. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71783
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1 · Lizenz 2